Filtern nach Last updated date SelectDanachVorFrom - To Date Enddatum Diese Woche Diesen Monat Letzte Woche Letzter Monat Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Bitte dieses Feld leer lassen Filter Ergebnisse (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Bitte dieses Feld leer lassen EMA Management Board: highlights of October 2022 meeting 7 Oktober 2022NewsCorporate Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022 7 Oktober 2022NewsVeterinaryMedicines Chair of the European Network of Paediatric Research at EMA re-elected 5 Oktober 2022NewsMedicinesPaediatrics Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 Oktober 2022News Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 September 2022NewsCorporate New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 September 2022NewsHumanMedicinesReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 September 2022NewsHumanPharmacovigilanceReferrals EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 September 2022NewsHumanAdvanced therapiesMedicines New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 September 2022NewsCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 September 2022NewsHumanCOVID-19Medicines 1 … 38 39 40 41 42 Page 42 of 383 43 44 45 46 … 383
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022 7 Oktober 2022NewsVeterinaryMedicines
Chair of the European Network of Paediatric Research at EMA re-elected 5 Oktober 2022NewsMedicinesPaediatrics
Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 Oktober 2022News
Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 September 2022NewsCorporate
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 September 2022NewsHumanMedicinesReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 September 2022NewsHumanPharmacovigilanceReferrals
EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 September 2022NewsHumanAdvanced therapiesMedicines
New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 September 2022NewsCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 September 2022NewsHumanCOVID-19Medicines